Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The widespread application of GLP-1 receptor agonists at the population level may impose significant financial pressure on pharmaceutical budgets, with modeling studies indicating that treating all eligible individuals with diabetes and obesity might need a 1020% rise in drug expenditures in several nations
Lam CSP, Ramasundarahettige C, Branch KRH et al (2022) Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O Trial
Major challenges in TDDS include limited drug-loading capacity and inadequate skin penetration, due to the low mechanical strength of polymeric microneedles or variations in skin properties between individuals
13 C-labelled metabolites were first identified based on their chromatographic retention time obtained from AMDIS
doi: 10.1111/jcmm.13259 38 ShimodaMKandaYHamamotoSTawaramotoKHashiramotoMMatsukiMet al
This hormone plays a key role in controlling blood sugar levels and controlling appetite
